Jacobs Levy Equity Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
2,473
-13,110
-84% -$3.48M ﹤0.01% 682
2026
Q1
$1.71M Buy
15,583
+13,416
+619% +$1.91M 0.01% 613
2025
Q4
$361K Buy
+2,167
New +$363K ﹤0.01% 842
2025
Q3
Sell
-6,690
Closed -$605K 1141
2025
Q2
$605K Hold
6,690
﹤0.01% 852
2025
Q1
$399K Hold
6,690
﹤0.01% 947
2024
Q4
$886K Buy
+6,690
New +$628K ﹤0.01% 731

Other funds holding ALAB

Jacobs Levy Equity Management's ALAB Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its Astera Labs (ALAB) stake by 84% in Q2 2026, selling an estimated $3.48M and leaving 2,473 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Jacobs Levy Equity Management first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.71M in Q1 2026. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Jacobs Levy Equity Management held 2,473 shares of Astera Labs worth $1.19M as of Q2 2026.
  • Jacobs Levy Equity Management sold 13,110 Astera Labs shares in Q2 2026, an estimated $3.48M.
  • Astera Labs made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #682 holding.
  • Jacobs Levy Equity Management first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Jacobs Levy Equity Management's Astera Labs position peaked at $1.71M in Q1 2026.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.